ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNR vs BDSX // ENTERPRISE SCALE & MARKET CAP

Burning Rock Biotech Limited (NASDAQ) VS. Biodesix Inc. (NASDAQ) • 15-METRIC TALLY: BNR 4 — BDSX 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BDSX
market-cap
$260.8M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNR VS. BDSX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNR BDSX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 74.70% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -4.14% -9.02% +4.88 BNR /fcf-yield <GO>
Operating Margin -10.20% -31.50% +21.30 BNR /operating-margins <GO>
Net Profit Margin -10.30% -39.90% +29.60 BNR /net-margins <GO>
Revenue Growth (YoY) 9.20% 24.10% -14.90 BDSX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 5/9 4/9 +1.00 BNR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 39.1 50.1 -11.00 BDSX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $116.5M $260.8M -$144.3M BDSX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNR REV BDSX REV BNR GROSS % BDSX GROSS % BNR FCF BDSX FCF
FY 2025 $77.2M $88.5M 74.7% — -$4.8M -$23.5M
FY 2024 $70.7M $71.3M 70.3% — -$13.4M -$51.9M
FY 2023 $75.7M $49.1M — — -$36.0M -$22.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNR // BETA —
BDSX // BETA —